Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting - Wikidata - awgldk - TriplyDB

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

http://www.wikidata.org/entity/Q33886138

about

Treatment of Breakthrough and Refractory Chemotherapy-Induced Nausea and Vomiting Cheaper Options in the Prevention of Chemotherapy-Induced Nausea and Vomiting.Prevention of chemotherapy-induced nausea: the role of neurokinin-1 (NK1) receptor antagonists.

P2860

Q26784070-6C4A439D-158C-4B03-9389-D88F29AE7732 Q33866119-91A61F63-1D09-45B3-AAF4-2D86A9ADFA55 Q37736060-A4C0EAF7-3E38-49ED-98C9-556C874BD9F6

P2860

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

http://www.wikidata.org/entity/Q33886138

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@ast

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@en

type

label

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@ast

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@en

prefLabel

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@ast

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@en

P1433

Q33886138-090F0E0D-E816-4778-AABC-0F7E9B4F1C59

P1476

Q33886138-AFC3CAA3-AA0D-43E2-987B-A31C37ADB32F

P2093

Q33886138-78C3289A-BDA7-4D66-8A80-995D3CD656C8

Q33886138-CC3D8D40-277C-4575-B565-B18F88E337C5

P2860

Q33886138-072AED27-D54A-448A-8FD6-7B10BFA8A907

Q33886138-37C2B728-EB6C-4B79-9255-093369F7CBC4

Q33886138-41378730-8051-4C19-BB10-03C16414AC47

Q33886138-933AF60E-97CC-4750-B84F-BE7661A64B2F

Q33886138-975C6D69-C593-44A1-AA1C-2973E2FB7477

Q33886138-9E4042B6-CFA3-4578-B748-FBB620450A86

Q33886138-BA12E0C6-0674-41E9-B3CA-3369606EC602

Q33886138-C96B622F-FFDC-4555-AFC8-6B9FD503E92C

Q33886138-D608B230-2F9E-43A8-8691-CBE17C9EAD45

Q33886138-ECEC06C9-1C5A-4257-A1FF-7FDE687838D1

P304

Q33886138-0624CDFC-1EED-425B-9AFD-35CF1CFD7B6C

P31

Q33886138-9D373140-EF0F-4D1A-96B4-918028DA24AD

P356

Q33886138-63C7D91C-D70A-4728-BE41-FE94C5B512F5

P433

Q33886138-879F9220-AC52-4528-A2B6-819980ED39C1

P478

Q33886138-EA7742C1-732C-40EC-B27F-49CF3D7E5BEA

P577

Q33886138-8B2CF7BF-4F6E-464C-B2FD-3568F59066B3

P698

Q33886138-5AC83B00-0505-426A-A975-5F4C45D57867

P932

Q33886138-196F9072-17A6-4040-8205-680701937625

P356

JADPRO.2014.5.1.8

P1433

Journal of the advanced practitioner in oncology

P1476

Olanzapine: an antiemetic option for chemotherapy-induced nausea and vomiting

@en

P2093

Ashley Glode

http://www.w3.org/2001/XMLSchema#string

Megan V Brafford

http://www.w3.org/2001/XMLSchema#string

P2860

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study.

Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.

The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy.

Clinical research of Olanzapine for prevention of chemotherapy-induced nausea and vomiting.

Pharmacological management of chemotherapy-induced nausea and vomiting: focus on recent developments.

A pilot exploration of the antiemetic activity of olanzapine for the relief of nausea in patients with advanced cancer and pain.

Olanzapine as an antiemetic in refractory nausea and vomiting in advanced cancer.

A phase I trial of olanzapine (Zyprexa) for the prevention of delayed emesis in cancer patients: a Hoosier Oncology Group study.

A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study.

P304

24-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.6004/JADPRO.2014.5.1.8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25032030

http://www.w3.org/2001/XMLSchema#string

P932

4093458

http://www.w3.org/2001/XMLSchema#string